Ingelvac PRRS MLV (Canada)

Company: Boehringer Ingelheim Animal Health

Porcine Reproductive and Respiratory Syndrome Vaccine

Reproductive and Respiratory Forms, Modified Live Virus

For use in animals only

Ingelvac PRRS MLV Indications

This product has been shown to be effective for the vaccination of healthy swine 3 weeks of age or older against reproductive and respiratory disease caused by Porcine Reproductive and Respiratory Syndrome (PRRS) virus. The duration of immunity is at least 4 months. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

Directions and dosage: Rehydrate the Ingelvac^® PRRS MLV vaccine by adding a portion of the contents of the accompanying liquid Sterile Diluent to the vaccine vial. Shake gently until reconstituted. Transfer the reconstituted suspension back into the diluent bottle, mixing with the remaining diluent to complete to a total volume of 100 mL. Shake well and use immediately. Sows and gilts: Using aseptic technique, inject a single 2 mL dose intramuscularly for the reproductive form of PRRS. Sows and gilts may be vaccinated prior to breeding or at any stage of pregnancy. Vaccination can either be population-targeted as a whole-herd vaccination program where all pregnant and nonpregnant sows and gilts are vaccinated every 3-4 months, or individual animal-targeted by vaccination 3 to 4 weeks prior to each breeding, or as directed by your herd veterinarian. Piglets: Using aseptic technique, inject a single 2 mL dose intramuscularly for the respiratory form of PRRS.

Precautions

Store out of direct sunlight at 2-8°C (35-46°F). Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Do not mix with other products, except as specified on the label. In case of anaphylactoid reaction, administer epinephrine. Do not vaccinate breeding age boars. In case of human exposure, contact a physician. Inactivate unused contents before disposal. Indicated for use in PRRS virus-positive herds only. Vaccine virus may be shed and transmitted to other populations of swine in contact with vaccinated swine. The duration of potential vaccine virus transmission may vary. Administer only to healthy pigs, gilts, or sows in PRRS virus positive herds, and only by intramuscular injection. Use of the vaccine in herds intended to remain PRRS virus seronegative is contraindicated. Introduction of vaccinated pigs into herds intended to remain PRRS virus seronegative is contraindicated. Specific herds may be particularly sensitive. Fetal health risks associated with vaccination of pregnant animals with this vaccine cannot be unequivocally determined by clinical trials conducted for licensure. Appropriate strategies to address the risks associated with vaccine use in pregnant animals should be discussed with a veterinarian.

Preservative: Neomycin.

Ingelvac^® PRRS is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license.

Manufactured by:

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, Missouri 64506 U.S.A.

Tel: 1 (888) 637-4251

VLN/PCN 124/19T1.20

Manufactured for:

Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

CPN: 1182242.0